163210-22-8 Usage
Uses
Used in Pharmaceutical Synthesis:
Tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate is utilized as an intermediate in the synthesis of various pharmaceuticals and research chemicals. Its presence as a key component in the production process is attributed to its ability to facilitate the creation of diverse drug candidates.
Used in Drug Development:
In the drug development industry, tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate is employed as a structural component to enhance the biological activity of potential drug candidates. The presence of the tert-butyl group and the 3-hydroxypropyl side chain allows for structural modifications, which can improve the efficacy and selectivity of these drug candidates.
Used in Research Chemicals:
Tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate also serves as a vital component in the synthesis of research chemicals, where its unique structural features contribute to the exploration of new chemical entities and the advancement of scientific understanding in medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 163210-22-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,2,1 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 163210-22:
(8*1)+(7*6)+(6*3)+(5*2)+(4*1)+(3*0)+(2*2)+(1*2)=88
88 % 10 = 8
So 163210-22-8 is a valid CAS Registry Number.
163210-22-8Relevant academic research and scientific papers
PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE
-
Paragraph 0917; 1033, (2020/07/07)
The present invention provides a compound represented by formula [I] shown below or a pharmaceutically acceptable salt thereof that has an inhibitory effect on 20-HETE producing enzyme. (in formula [I] above, the structure represented by formula [II] below: represents any of the structures represented by formula group [III] below: R1, R2, R3, and R4 independently represent a hydrogen atom, a fluorine atom, methyl, or the like, R5 represents any of the structures represented by formula group [IV]:
THERAPEUTIC COMPOUNDS
-
, (2018/07/06)
no abstract published
NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF
-
Paragraph 1638, (2013/07/25)
The invention relates to pyridinyl nicotinic acetylcholine receptor ligands, compositions comprising an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand and methods to treat or prevent a condition, such as depression and nicotine dependence, comprising administering to an animal in need thereof an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand.
Fibrinogen receptor antagonists
-
, (2008/06/13)
Novel fibrinogen receptor antagonists of the formula: are provided in which the claimed compounds exhibit fibrinogen receptor antagonist activity, inhibit platelet aggregation and are therefore useful in modulating thrombus formation.
